Phathom Pharmaceuticals
PHAT
PHAT
76 hedge funds and large institutions have $815M invested in Phathom Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more capital invested
Capital invested by funds: $794M → $815M (+$21.3M)
27% less call options, than puts
Call options by funds: $359K | Put options by funds: $491K
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
76
Holding in Top 10
5
Calls
$359K
Puts
$491K
Top Buyers
| 1 | +$23.2M | |
| 2 | +$12.3M | |
| 3 | +$11M | |
| 4 |
JG
Jefferies Group
New York
|
+$8.22M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$5.81M |
Top Sellers
| 1 | -$5.69M | |
| 2 | -$1.97M | |
| 3 | -$1.17M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$855K |
| 5 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
-$782K |